Navigation Links
Success of anti-meth ads questioned by study
Date:12/10/2008

Washington, DC, December 11, 2008-- An independent review investigating the effectiveness of a publicly funded graphic anti-methamphetamine advertising campaign has found that the campaign has been associated with many negative outcomes. The review was published in the December issue of Prevention Science, a peer reviewed journal of the Society for Prevention Research (SPR).

The Montana Meth Project (MMP) was created in 2005 to reduce methamphetamine use in Montana via graphic advertising showing extreme consequences of using meth "just once." Initially the ad campaign was privately funded, but it has since received millions of dollars in state and federal support as the MMP has promoted the ad campaign as a resounding success to policy makers and the media. Based on the apparent success of the ad campaign in Montana, it has since been implemented in other states including Arizona, Idaho, and Illinois, with more states to follow.

The negative outcomes identified in the review include: following six months exposure to the MMP's graphic ads, there was a threefold increase in the percentage of teenagers who reported that using meth is not a risky behaviour; teenagers were four times more likely to strongly approve of regular meth use; teenagers were more likely to report that taking heroin and cocaine is not risky; and up to 50% of teenagers reported that the graphic ads exaggerate the risks of using meth.

The review found that the MMP overlooked these unflattering results when promoting their research findings to policymakers and the media. Instead, the MMP focused on select positive findings.

The author of the review, David Erceg-Hurn, who is currently completing his PhD in Clinical Psychology at the University of Western Australia, came across the Meth Project while conducting research on graphic tobacco advertising. There was a mention of the Meth Project in an article he read. Erceg-Hurn followed up on that mention and closely scrutinized the Meth Project's research reports. He said that it is important for organizations that are funding or considering funding the MMP's ad campaign to be made aware of all of the MMP's findings - positive and negative. To date, this has not happened.

Erceg-Hurn also criticized claims that the ad campaign has been responsible for reducing meth use in Montana. "Meth use had been declining for at least six years before the ad campaign commenced, which suggests that factors other than the graphic ads cause reductions in meth use. Another issue is that the launch of the ad campaign coincided with restrictions on the sale of cold and flu medicines commonly used in the production of meth. This means that drug use could be declining due to decreased production of meth, rather than being the result of the ad campaign."

Erceg-Hurn also pointed out in his review that due to the way the MMP has conducted their research, it is impossible to conclude that the ad campaign had any effect on meth use. To draw such conclusions would require much more rigorous research. This would involve examining two groups of teenagers that were equivalent in terms of drug use, exposing only one group to the graphic ads, and then examining any differences between the groups in their drug use.

The theory underlying the MMP's ad campaign was also criticized by Erceg-Hurn. "The idea behind the ad campaign is that teenagers take meth because they believe it is socially acceptable, and not risky - and the ads are meant to alter these perceptions. However, this theory is flawed because the Meth Project's own data shows that 98% of teenagers strongly disapproved of meth use and 97% thought using meth was risky before the campaign started."

The review also points out that considerable prior research has found that large anti-drug advertising campaigns can be ineffective and sometimes harmful. For example, the National Youth Anti-Drug Media Campaign has cost taxpayers over $1.5 billion since 1998. A Government Accountability Office report found that the ad campaign has not reduced drug use. The only significant results were in an unfavorable direction - some youths reported an increase in marijuana use upon increased exposure to the campaign.

Erceg-Hurn concluded in his Prevention Science review that based on current evidence, continued public funding and rollout of Montana-style anti-methamphetamine graphic ad campaign programs is inadvisable.


'/>"/>

Contact: David Erceg-Hurn
david.erceg-hurn@grs.uwa.edu.au
01-161-403-990-346
Society for Prevention Research
Source:Eurekalert

Related medicine news :

1. Research Shows Successful Physician Engagement in LifeMasters Disease Management Programs
2. Hawaii Eye Surgeon Receives Small Business Success Award
3. MonoSol Rx Successfully Completes Pivotal Bioequivalence Studies for Ondansetron Thin Film NDA
4. The Ensign Group Successfully Graduates Second Nursing Home From CMS Special Focus Program
5. Plastic Surgery Journal Shows New Groundbreaking Genital Cosmetic Procedure for Women to be Successful
6. MEDRAD Builds on Success of P3T Cardiac CT Injection Software
7. Gentiva Health Services Confirms Management Succession
8. Brim Healthcare and Broadlane Continue Successful, Exclusive Relationship
9. As Chairman Baucus Outlines Vision for Healthcare Reform, NACDS Emphasizes Pharmacy's Essential Role in Any Successful Overhaul
10. PARI Pharma Completes Successful Clinical Trials for Tobramycin 100 & Investigational eFlow for CF
11. Research Identifies Predictors for Successful IVF
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... 2016 , ... Castle Dermatology Institute is now offering liquid facelifts with ... appearance to the face. Dr. Peyman Ghasri and Dr. Pedram Ghasri, San Fernando ... to rejuvenate and renew the facial appearance. , Sculptra is a highly effective ...
(Date:12/7/2016)... ... December 07, 2016 , ... When it came time to blow out his candles on ... later, the Pediatric Heart Transplant team at Joe DiMaggio Children’s Hospital surprised his ... the hospital’s 30th heart transplant recipient. , “He was playing at home, when we ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... insurance and financial planning services to families and business owners in the greater ... on behalf of the Dallas Fallen Officer Foundation. , Established in 2009 by ...
(Date:12/7/2016)... ... OCTOBER XX, 2016 (PRWEB) (PRWEB) December 07, 2016 ... ... A new study entitled “Canine Filamentous Dermatitis Associated with Borrelia Infection” ... dogs. The study was published in the prestigious Journal of Veterinary Science & ...
(Date:12/7/2016)... ... ... Delete® - Tattoo Removal and Laser Salon Offers Delightful Holiday Deals On Botox® ... Off Botox® and Juvederm® Products Now Through December 31, 2016 , Delete® - Tattoo ... on Botox® and Juvederm® just in time for the holiday party season. , To ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... PALO ALTO, Calif. , Dec. 7, 2016 /PRNewswire/ ... announced an update to its previously announced plans to ... to be executed via a tax-free distribution to Varian ... new stand-alone public company that will hold the Imaging ... now expected to be executed by the end of ...
(Date:12/7/2016)... 7, 2016  Organovo Holdings, Inc. (NASDAQ: ... focused on delivering scientific and medical breakthroughs using ... and Chief Executive Officer Keith Murphy ... December 14, 2016 at 1:00 p.m. Eastern Time ... yet familiar with the Company, an informational video ...
(Date:12/7/2016)... PHILADELPHIA , Dec. 7, 2016  Lannett Company, Inc. (NYSE: ... at the BMO Capital Markets 2016 Prescription for Success Healthcare Conference ... Barclay hotel in New York City . ... investors participating at the Guggenheim Securities 4 th Annual Boston ... Boston hotel. ...
Breaking Medicine Technology: